arrow
U

Ute M. Moll

department of pathology
H指数:72
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition

通过p53激活或细胞周期抑制中断HSF1-HSP90轴以增强结直肠癌疗法

2025-04-090
OA
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer (April ,10.1038/s41375-024-02253-3, 2024)
LEUKEMIA
IF13.4
2024-05-070
OAAI
Dynamics of clonal hematopoiesis under DNA-damaging treatment in patients with ovarian cancer

DNA损伤治疗下卵巢癌患者克隆造血的动态变化

LEUKEMIA
IF13.4
2024-04-185
OAAI
Apoptotic cell death in disease-Current understanding of the NCCD 2023

疾病中的凋亡细胞死亡-对NCCD 2023的当前理解

2023-04-26143
OAAI
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
2019-09-1025
OAAI
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

细胞死亡的分子机制: 细胞死亡2018命名委员会的建议

2018-01-234.5K
OAAI
Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice
2017-03-1465
OAAI